id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-1946-0013,FDA,FDA-2019-E-1946,Response to Notice of Final Determination and Withdrawal of Patent Term Extension Application,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T20:42:36Z,,0,0,0900006486612edc
FDA-2019-E-1946-0012,FDA,FDA-2019-E-1946,Withdrawal of Application for Patent Term Extension,Other,Letter(s),2024-07-31T04:00:00Z,2024,7,2024-07-31T04:00:00Z,,2024-07-31T12:09:39Z,,0,0,0900006486605ed9
FDA-2019-E-1946-0011,FDA,FDA-2019-E-1946,Notice of Final Determination and Requirement for Election,Other,Letter(s),2024-03-18T04:00:00Z,2024,3,2024-03-18T04:00:00Z,,2024-03-18T19:19:12Z,,0,0,090000648647b426
FDA-2019-E-1946-0009,FDA,FDA-2019-E-1946,Requirement for Information Pursuant to 37 CFR 1.750,Other,Letter(s),2024-03-18T04:00:00Z,2024,3,2024-03-18T04:00:00Z,,2024-03-18T19:18:53Z,,0,0,090000648647b436
FDA-2019-E-1946-0010,FDA,FDA-2019-E-1946,Response to Requirement for Information Pursuant to 37 CFR 1.750,Other,Response(s),2024-03-18T04:00:00Z,2024,3,2024-03-18T04:00:00Z,,2024-03-18T19:18:59Z,,0,0,090000648647b451
FDA-2019-E-1946-0008,FDA,FDA-2019-E-1946,Letter from FDA CDER to U S Patent and Trademark Office,Other,Letter(s),2024-02-05T05:00:00Z,2024,2,2024-02-05T05:00:00Z,,2024-02-05T15:15:52Z,,0,0,09000064863db5f8
FDA-2019-E-1946-0007,FDA,FDA-2019-E-1946,Letter from U. S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-01-17T05:00:00Z,2024,1,2024-01-17T05:00:00Z,,2024-01-17T19:19:00Z,,0,0,0900006486390171
FDA-2019-E-1946-0006,FDA,FDA-2019-E-1946,Determination of Regulatory Review Period for Purposes of Patent Extension; LOKELMA,Notice,Determinations,2023-02-08T05:00:00Z,2023,2,2023-02-08T05:00:00Z,2023-04-11T03:59:59Z,2023-02-08T19:53:31Z,2023-02667,0,0,090000648563e93e
FDA-2019-E-1946-0005,FDA,FDA-2019-E-1946,Letter from FDA CDER TO U.S. Patent and Trademark Office,Other,Letter(s),2023-02-02T05:00:00Z,2023,2,2023-02-02T05:00:00Z,,2023-02-02T17:29:41Z,,0,0,090000648562d1b4
FDA-2019-E-1946-0004,FDA,FDA-2019-E-1946,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T21:20:47Z,,0,0,090000648555f83d
FDA-2019-E-1946-0003,FDA,FDA-2019-E-1946,Letter from FDA to U.S. Patent and Trademark Office,Other,Letter(s),2019-06-21T04:00:00Z,2019,6,2019-06-21T04:00:00Z,,2019-06-21T14:24:59Z,,0,0,0900006483d30819
FDA-2019-E-1946-0002,FDA,FDA-2019-E-1946,"Patent Extension Application from Arent Fox LLP (on behalf of ZS Pharma, Inc.)",Other,Application,2019-04-23T04:00:00Z,2019,4,2019-04-23T04:00:00Z,,2019-04-23T19:52:04Z,,0,0,0900006483be6d39
FDA-2019-E-1946-0001,FDA,FDA-2019-E-1946,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2019-04-23T04:00:00Z,2019,4,2019-04-23T04:00:00Z,,2019-04-23T19:48:33Z,,0,0,0900006483be68da